Going public: the role of public participation approaches in commercial AI labs

In recent years, discussions of responsible AI practices have seen growing support for "participatory AI" approaches, intended to involve members of the public in the design and development of AI systems. Prior research has identified a lack of standardised methods or approaches for how to use participatory approaches in the AI development process. At present, there is a dearth of evidence on attitudes to and approaches for participation in the sites driving major AI developments: commercial AI labs. Through 12 semi-structured interviews with industry practitioners and subject-matter experts, this paper explores how commercial AI labs understand participatory AI approaches and the obstacles they have faced implementing these practices in the development of AI systems and research. We find that while interviewees view participation as a normative project that helps achieve "societally beneficial" AI systems, practitioners face numerous barriers to embedding participatory approaches in their companies: participation is expensive and resource intensive, it is "atomised" within companies, there is concern about exploitation, there is no incentive to be transparent about its adoption, and it is complicated by a lack of clear context. These barriers result in a piecemeal approach to participation that confers no decision-making power to participants and has little ongoing impact for AI labs. This papers contribution is to provide novel empirical research on the implementation of public participation in commercial AI labs, and shed light on the current challenges of using participatory approaches in this context.

Does "AI" stand for augmenting inequality in the era of covid-19 healthcare?

Among the most damaging characteristics of the covid-19 pandemic has been its disproportionate effect on disadvantaged communities. As the outbreak has spread globally, factors such as systemic racism, marginalisation, and structural inequality have created path dependencies that have led to poor health outcomes. These social determinants of infectious disease and vulnerability to disaster have converged to affect already disadvantaged communities with higher levels of economic instability, disease exposure, infection severity, and death. Artificial intelligence (AI) technologies are an important part of the health informatics toolkit used to fight contagious disease. AI is well known, however, to be susceptible to algorithmic biases that can entrench and augment existing inequality. Uncritically deploying AI in the fight against covid-19 thus risks amplifying the pandemic's adverse effects on vulnerable groups, exacerbating health inequity. In this paper, we claim that AI systems can introduce or reflect bias and discrimination in three ways: in patterns of health discrimination that become entrenched in datasets, in data representativeness, and in human choices made during the design, development, and deployment of these systems. We highlight how the use of AI technologies threaten to exacerbate the disparate effect of covid-19 on marginalised, under-represented, and vulnerable groups, particularly black, Asian, and other minoritised ethnic people, older populations, and those of lower socioeconomic status. We conclude that, to mitigate the compounding effects of AI on inequalities associated with covid-19, decision makers, technology developers, and health officials must account for the potential biases and inequities at all stages of the AI process.